Anti-infection
-
BA2294 SARS-CoV-2-IN-7Summary: SARS-CoV-2-IN-7 in SARS-CoV-2-infected VeroE6 cells in nanomoles. -
BA2295 SARS-CoV-2-IN-39Summary: SARS-CoV-2-IN-39 (compound 21) is an inhibitor. -
BA2296 LY1Summary: LY1 is a potent and selective covalent inhibitor against and. -
BA2297 MERS-CoV-IN-1Summary: Compositions of active molecules that can be used as prophylaxis against diseases caused by MERS-CoV and SARS viruses. -
BA2298 SARS-CoV-2-IN-14Summary: SARS-CoV-2-IN-14 is a potent inhibitor. -
BA2299 SSAA09E3Summary: SSAA09E3 is an entry inhibitor. -
BA2300 SHEN26Summary: SHEN26 (ATY014) is a potent, orally active inhibitor. -
BA2303 RdRP-IN-2Summary: RdRP-IN-2 is an RNA-dependent inhibitor of RNA polymerase. -
BA2304 XP-59Summary: XP-59 is an effective inhibitor. -
BA2305 CnicinSummary: Cnicin is a sesquiterpene lactone.
